In pancreatic beta cells, ATP−potassium channels are crucial for the regulation of glucose-stimulated insulin secretion and are the target for the sulfonylureas which are oral hypoglycemic agents widely used in the treatment of T2D and for diazoxide, a potassium channel opener. The gene discussed is INS; the disease is type 2 diabetes mellitus.